{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:11:02Z","timestamp":1757617862540,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The impact of apical lymph node (ALN) status on the prognosis of colorectal cancer (CRC) remains controversial, and ALN status is not included in the current Tumor Node Metastasis (TNM) staging system. This study aimed to evaluate the effect of ALN status on recurrence and survival rates. In this retrospective study, 117 stage 3 CRC patients aged over 18 who underwent surgery between 2015 and 2024 and had their ALN status determined were evaluated. Patients with metastatic disease at diagnosis, those with undetermined ALN status, and those with concurrent malignancies were excluded. Patients were analyzed based on demographic, clinical, pathological, and survival data. The median age was 61\u00a0years (range: 33\u201383), and 60.7% of the patients were male. The pN stage was significantly more advanced (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and the number of metastatic lymph nodes was significantly higher (<jats:italic>p<\/jats:italic>\u2009=\u20090.003) in the ALN (\u2009+) group. During a median follow-up of 46\u00a0months, 14 local recurrences, 31 systemic recurrences, and 27 cancer-related deaths were observed. Local recurrence, systemic recurrence, and cancer-related deaths were significantly more frequent in the ALN (\u2009+) group (<jats:italic>p<\/jats:italic>\u2009=\u20090.027, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, respectively). Locoregional disease-free survival, systemic disease-free survival and overall survival were significantly shorter in the ALN (\u2009+) group (<jats:italic>p<\/jats:italic>\u2009=\u20090.011, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, respectively). In multivariate analysis, SDFS and OS were found to be significantly shorter in the ALN (\u2009+) and pN2 groups. ALN metastasis can be considered as an additional adverse prognostic factor in CRC beyond the pN stage.<\/jats:p>","DOI":"10.1007\/s13304-025-02219-9","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:15:28Z","timestamp":1746429328000},"page":"1009-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Poor prognosis in stage III colorectal cancer with apical lymph node metastasis: a single-center retrospective study"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3133-9627","authenticated-orcid":false,"given":"Burak","family":"Din\u00e7er","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0380-9190","authenticated-orcid":false,"given":"Ahmet","family":"Karayi\u011fit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-3333","authenticated-orcid":false,"given":"Fatma","family":"Marko\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-9662","authenticated-orcid":false,"given":"Serdar","family":"Sar\u0131demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2611-4837","authenticated-orcid":false,"given":"Cihangir","family":"\u00d6zaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"2219_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"2219_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.hoc.2022.02.001","volume":"36","author":"S Gupta","year":"2022","unstructured":"Gupta S (2022) Screening for colorectal cancer. Hematol Oncol Clin North Am 36:393\u2013414. https:\/\/doi.org\/10.1016\/j.hoc.2022.02.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"2219_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soc.2013.09.013","volume":"23","author":"F Denstman","year":"2014","unstructured":"Denstman F (2014) An approach to the newly diagnosed colorectal cancer patient with synchronous stage 4 disease. Surg Oncol Clin N Am 23:151\u2013160. https:\/\/doi.org\/10.1016\/j.soc.2013.09.013","journal-title":"Surg Oncol Clin N Am"},{"key":"2219_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 67:93\u201399. https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"2219_CR5","doi-asserted-by":"crossref","unstructured":"(2019) Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3d English edition [Secondary Publication]. J Anus Rectum Colon, 3, 175\u2013195","DOI":"10.23922\/jarc.2019-018"},{"key":"2219_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/00000421-198812000-00027","volume":"11","author":"OH Beahrs","year":"1988","unstructured":"Beahrs OH, Henson DE, Hutter RVP, Myers MH (1988) Manual for staging of cancer. Am J Clin Oncol 11:686","journal-title":"Am J Clin Oncol"},{"key":"2219_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-642-82982-6_3","volume-title":"TNM classification of malignant tumours","author":"P Hermanek","year":"1987","unstructured":"Hermanek P, Sobin LH (1987) Digestive system tumours. In: Hermanek P, Sobin LH (eds) TNM classification of malignant tumours. Springer, Berlin Heidelberg, pp 37\u201367"},{"key":"2219_CR8","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1002\/cncr.35491","volume":"130","author":"N Bhutiani","year":"2024","unstructured":"Bhutiani N, Peacock O, Uppal A, Hu CY, Bednarski BK, Taggart MW, Dasari A, Morris VK, Kaur H, Kopetz S, Holliday EB, Das P, You YN, Chang GJ (2024) The prognostic impact of tumor deposits in colorectal cancer: more than just N1c. Cancer 130:4052\u20134060. https:\/\/doi.org\/10.1002\/cncr.35491","journal-title":"Cancer"},{"key":"2219_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s13304-024-01770-1","volume":"76","author":"C Lu","year":"2024","unstructured":"Lu C, Wang Z, Huang Y, Ji P, Luo X, Chu C, Yu C (2024) Evaluation of the prognostic performance of different cutoff values of lymph node ratio staging system for stage III colorectal cancer. Updates Surg 76:1311\u20131320. https:\/\/doi.org\/10.1007\/s13304-024-01770-1","journal-title":"Updates Surg"},{"key":"2219_CR10","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1038\/s41598-022-06054-5","volume":"12","author":"K Ishii","year":"2022","unstructured":"Ishii K, Watanabe J, Goto K, Suwa Y, Nakagawa K, Suwa H, Ozawa M, Ishibe A, Kunisaki C, Endo I (2022) The prognostic significance of apical lymph node metastasis in patients with high-risk stage III colon cancer. Sci Rep 12:2059. https:\/\/doi.org\/10.1038\/s41598-022-06054-5","journal-title":"Sci Rep"},{"key":"2219_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jamcollsurg.2006.02.007","volume":"202","author":"O Suzuki","year":"2006","unstructured":"Suzuki O, Sekishita Y, Shiono T, Ono K, Fujimori M, Kondo S (2006) Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer. J Am Coll Surg 202:732\u2013736. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2006.02.007","journal-title":"J Am Coll Surg"},{"key":"2219_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00384-011-1271-z","volume":"27","author":"JW Yi","year":"2012","unstructured":"Yi JW, Lee TG, Lee HS, Heo SC, Jeong SY, Park KJ, Kang SB (2012) Apical-node metastasis in sigmoid colon or rectal cancer: is it a factor that indicates a poor prognosis after high ligation? Int J Colorectal Dis 27:81\u201387. https:\/\/doi.org\/10.1007\/s00384-011-1271-z","journal-title":"Int J Colorectal Dis"},{"key":"2219_CR13","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00384-020-03661-4","volume":"35","author":"LM Wang","year":"2020","unstructured":"Wang LM, Hirano YM, Ishii TM, Kondo HK, Hara KK, Obara N, Asari MH, Yamaguchi SK (2020) The role of apical lymph node metastasis in right colon cancer. Int J Colorectal Dis 35:1887\u20131894. https:\/\/doi.org\/10.1007\/s00384-020-03661-4","journal-title":"Int J Colorectal Dis"},{"key":"2219_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13000-024-01449-6","volume":"19","author":"AF Beirat","year":"2024","unstructured":"Beirat AF, Amarin JZ, Suradi HH, Qwaider YZ, Muhanna A, Maraqa B, Al-Ani A, Al-Hussaini M (2024) Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma. Diagn Pathol 19:44. https:\/\/doi.org\/10.1186\/s13000-024-01449-6","journal-title":"Diagn Pathol"},{"key":"2219_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-025-02743-z","author":"K Noda","year":"2025","unstructured":"Noda K, Tominaga T, Nonaka T, Ono R, Oishi K, Takamura Y, Shiraishi T, Hashimoto S, Hisanaga M, Takeshita H, Ishii M, Oyama S, Ishimaru K, Sawai T, Matsumoto K (2025) Survival paradox and effect of adjuvant chemotherapy for high-risk Stage II and low-risk Stage III colorectal cancer. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-025-02743-z","journal-title":"Int J Clin Oncol"},{"key":"2219_CR16","volume-title":"American society of anesthesiologists classification","author":"DJ Doyle","year":"2025","unstructured":"Doyle DJ, Hendrix JM, Garmon EH (2025) American society of anesthesiologists classification. StatPearls Publishing, StatPearls"},{"key":"2219_CR17","unstructured":"Copyright \u00a9 2025, StatPearls Publishing LLC., Treasure Island (FL)"},{"key":"2219_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/bjs.9548","volume":"101","author":"H Kawada","year":"2014","unstructured":"Kawada H, Kurita N, Nakamura F, Kawamura J, Hasegawa S, Kotake K, Sugihara K, Fukuhara S, Sakai Y (2014) Incorporation of apical lymph node status into the seventh edition of the TNM classification improves prediction of prognosis in stage III colonic cancer. Br J Surg 101:1143\u20131152. https:\/\/doi.org\/10.1002\/bjs.9548","journal-title":"Br J Surg"},{"key":"2219_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12029-022-00828-w","volume":"54","author":"M Hiraki","year":"2023","unstructured":"Hiraki M, Tanaka T, Sadashima E, Sato H, Kitahara K (2023) The clinical impact of apical lymph node metastasis of colorectal cancer after curative resection. J Gastrointest Cancer 54:506\u2013512. https:\/\/doi.org\/10.1007\/s12029-022-00828-w","journal-title":"J Gastrointest Cancer"},{"key":"2219_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12253-017-0381-5","volume":"25","author":"HL Tsai","year":"2019","unstructured":"Tsai HL, Chen YT, Yeh YS, Huang CW, Ma CJ, Wang JY (2019) Apical lymph nodes in the distant metastases and prognosis of patients with stage III colorectal cancer with adequate lymph node retrieval following FOLFOX adjuvant chemotherapy. Pathol Oncol Res 25:905\u2013913. https:\/\/doi.org\/10.1007\/s12253-017-0381-5","journal-title":"Pathol Oncol Res"},{"key":"2219_CR21","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.21873\/invivo.12129","volume":"34","author":"L Wang","year":"2020","unstructured":"Wang L, Hirano Y, Heng G, Ishii T, Kondo H, Hara K, Obara N, Asari M, Yamaguchi S (2020) Prognostic utility of apical lymph node metastasis in patients with left-sided colorectal cancer. In Vivo 34:2981\u20132989. https:\/\/doi.org\/10.21873\/invivo.12129","journal-title":"In Vivo"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02219-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02219-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02219-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:21:17Z","timestamp":1757164877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02219-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2219"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02219-9","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"type":"print","value":"2038-131X"},{"type":"electronic","value":"2038-3312"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the local ethics committee (October 31, 2024 \u2013 No: 2024-10\/153).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}